Alembics JV Aleor Receives US FDA Approval For Generic Axiron Topical Solution
Alembic Pharmaceuticals Limited announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for testosterone topical solution USP, 30 mg per pump actuation.The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Axiron topical solution, 30 mg per pump actuation, of Eli Lilly and Company (Lilly).Testosterone topical solution USP, 30 mg per pump actuation is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).Testosterone topical solution USP, 30 mg per pump actuation has an estimated market size of US$ 21 million for twelve months ending March 2021 according to IQVIA.Alembic has a cumulative total of 145 ANDA approvals (127 final approvals and 18 tentative approvals) from US FDA.

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!